Review
doi: 10.1016/s1471-4914(02)02330-4.
Molecular insights into Friedreich's ataxia and antioxidant-based therapies
Affiliations
- PMID: 12067631
- DOI: 10.1016/s1471-4914(02)02330-4
Item in Clipboard
Review
Molecular insights into Friedreich's ataxia and antioxidant-based therapies
Trends Mol Med.
2002 May.
Abstract
Friedreich's ataxia (FRDA) is an autosomal recessive neurodegenerative disease causing limb and gait ataxia and cardiomyopathy. The disease gene encodes a mitochondrial protein of unknown function, frataxin. The loss of functional frataxin is caused by a large GAA trinucleotide expansion in the first intron of the gene, thus impairing gene transcription. The lack of frataxin appears to result primarily in disabled recruitment of early antioxidant defenses, resulting in oxidative insult to the highly sensitive iron-sulfur proteins aconitase and three mitochondrial respiratory chain complexes (I-III). Accordingly, antioxidant-based therapy appears promising in counteracting the course of the disease.
Similar articles
-
Heart hypertrophy and function are improved by idebenone in Friedreich's ataxia.Free Radic Res. 2002 Apr;36(4):467-9. doi: 10.1080/10715760290021333. Free Radic Res. 2002. PMID: 12069112
-
Mitochondrial dysfunction in Friedreich's ataxia: from pathogenesis to treatment perspectives.Free Radic Res. 2002 Apr;36(4):461-6. doi: 10.1080/10715760290021324. Free Radic Res. 2002. PMID: 12069111 Review.
-
The GAA repeat expansion in intron 1 of the frataxin gene is related to the severity of cardiac manifestation in patients with Friedreich's ataxia.J Mol Med (Berl). 2001;78(11):626-32. doi: 10.1007/s001090000162. J Mol Med (Berl). 2001. PMID: 11269509
-
Effect of idebenone on cardiomyopathy in Friedreich's ataxia: a preliminary study.Lancet. 1999 Aug 7;354(9177):477-9. doi: 10.1016/S0140-6736(99)01341-0. Lancet. 1999. PMID: 10465173
-
Friedreich's Ataxia: disease mechanisms, antioxidant and Coenzyme Q10 therapy.Biofactors. 2003;18(1-4):163-71. doi: 10.1002/biof.5520180219. Biofactors. 2003. PMID: 14695932 Review.
Cited by
-
Small molecules affecting transcription in Friedreich ataxia.Pharmacol Ther. 2007 Nov;116(2):236-48. doi: 10.1016/j.pharmthera.2007.06.014. Epub 2007 Aug 9. Pharmacol Ther. 2007. PMID: 17826840 Free PMC article. Review.
-
Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.BMC Med Genomics. 2009 Jan 8;2:2. doi: 10.1186/1755-8794-2-2. BMC Med Genomics. 2009. PMID: 19133145 Free PMC article.
-
Posttranslational regulation of mitochondrial frataxin and identification of compounds that increase frataxin levels in Friedreich's ataxia.J Biol Chem. 2022 Jun;298(6):101982. doi: 10.1016/j.jbc.2022.101982. Epub 2022 Apr 25. J Biol Chem. 2022. PMID: 35472330 Free PMC article.
-
Quantifying small molecule phenotypic effects using mitochondrial morpho-functional fingerprinting and machine learning.Sci Rep. 2015 Jan 26;5:8035. doi: 10.1038/srep08035. Sci Rep. 2015. PMID: 25620325 Free PMC article.
-
Yeast as a Tool for Deeper Understanding of Human Manganese-Related Diseases.Genes (Basel). 2019 Jul 17;10(7):545. doi: 10.3390/genes10070545. Genes (Basel). 2019. PMID: 31319631 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
